Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We’re due an update soon if I recall correctly.
BOOM. TIME TO GIDDY UP.
Yes! Please short!
Secret signals! LOL. This isn’t the OTC, Jr. again. Please short. EOM.
Please short. Please.
Dumpster fire? What a joke.
Lol. Have at it.
It will go thermonuclear. Not a doubt in my mind we’ll be sitting fat in the $20’s or $30’s.
BOOM CHAKALAKA
Let’s hope we both make some coin!
No he is correct about CUSIP, but the stock won’t be gummed up like it is on the OTC where we can’t sell for a day or so. That’s OTC (DCTH) garbage.
HAHA. Let’s see a big day tomorrow. Btw, it just dawned on me that Proffeti is wrong. CUSIP ‘issues’ only impact sh*tty OTC stocks. That’s why I never dabble in that garage.
Buckle up!
And yes, I cannot believe I am actually agreeing with you, lol.
Good luck.
Good point, re: cusip.
I jumped a week ago. But I have to say that hands down, this is the craziest message board I have ever read. Ever.
I don’t know if that’s good. Or bad. Just crazy.
Good luck all!
I hope they have some nice news tomorrow. That would be great.
Let’s see what the girl has in store this week. Dream scenario is RS tomorrow followed by PR tomorrow. Would love me some FDA update.
Forgive my ignorance for the following:
I understand the Amgen relationship ended in December, but what is their relationship with Merck?
Unfortunately those AH shares totaled maybe 65,000 shares. That’s roughly $32,000 for the whole lot.
I wouldn’t necessarily pin hopes of something big based on that purchase. Could be wrong, but...
Yeah I think my fever regarding the RS has passed (not really), but CRMD is in a much better position provided we don’t see active ATM use.
Do we know if management has made some type of commitment not to tap the ATM? They destroyed PPS spikes in Oct and Feb dumping shares. At least that’s my current operating theory.
They are fully funded through Q2 2020 so I will go ape shit if next Q they tapped another $5M-$10M just to stockpile.
The FDA is priority and let’s the P value shine baby!
Thank you kind sir. I am here and I’ve taken a position in Advaxis as well. You know me, Captain catalyst, lol.
This sector is intriguing on a number of levels and I can’t help but geek out on the science.
Good luck you today and every day!
Niiiice!!!
Is Janet still CRMD’s resident freeloader, or did she actually purchase shares out of pocket for once?
And yes, took a little position last week. Good information from posters on this thread. Thanks
CRMD won’t drop to $1.50. On fact, it will likely be over $2.00 prior to the RS. Any FDA update shortly after the 5:1 sends CRMD thermonuclear.
CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel
This is a really big hire-it speaks to the evolving maturity of the company when in-house GC comes on board.
Solid credentials as well.
I am still salty about the split, but this hire is a great move.
Time waits for no one? Tell that to all biotechs trying to cure all forms of cancer for the last 50 years or so.
The comedy, of course, is his use of the word “judicious”.
It was totally unnecessary. They could have tapped 50% less, have funding through Q3 19 and the stock would already be over $5.
When who pulls the trigger on what?
Khoso goes into the books as a pretty decent sized POS. From the last ER call on the 14th.
“During the fourth quarter of 2018, we continued to judiciously utilize our at-the-market facility, raising approximately $11 million net after commissions at an average price of $1.31 share. We were able to take further advantage of our ATM facility given the significant increase in our stock price during the first quarter of this year, raising an additional $15 million at an average price of $1.78 per share.”
But from an Option holder’s perspective, all 20,356 March $2.5 call options (representing 2,356,0000 shares), never stood a chance. Ever. By utililizing the ATM to raise $26,000,0000 net (after commissions), CRMD literally dumped 16,823,913 shares into the open market over a 5 ½ month period; an avg. rate of 3,058,89 per month.
Why let this market develop when the CEO knew the strike price was a complete joke.
Good luck all. I am still in CRMD but wow, talk about total loss of faith. Hopefully we’ll hear about FDA one of these days.
Bye bye. EOM.
Listen to the con call.
Okay. Bye. Great call on the PPS today.
Nice call. Lol.
Hell Yes! I believe she just had her coming out ball. This could be $4.00 before RS.
LoL. And back to back conferences next Monday and Tuesday but we’ve been dying on the vine since the Valentine’s Day massacre.
Hopefully Khoso gives some type of clear direction. GLTY!
EOD.